If sustain the current momentum - we can see a strong upside. Add to watchlist.
In the last 2 weeks - we see a slow and steady growth from 95 to 111. Expected to test 121 and beyond.
2022-07-18: Close is above SMA 20 on Daily/Weekly/Monthly time frames. M trend is +ve & W trend Change to +ve today. Price Crossed Upside 50-SMA on Monthly time frame. D13>34>55 & Close crossed D13 Up W Close Crossed W13 Upside. Also Normal NR7 - Breakout
2022-07-19: Cross WK Piv Upside & W SMA 13>34>55 & Close crossed W13 Upside
2022-07-20: SMA 30 crossed SMA 100 Upside. Possible Long. Also Crossing 4 week High
2022-07-21: Possible strong upside movement
2022-07-25: Spike in ADX. ADX >26 DI+ > 32 (Don't miss this)
2022-07-26: Increase in ADX. Also Normal NR7 - Inside Candle
2022-07-27: Normal NR7 - Breakout
2022-07-28: ADX>31, DI+> 33.0, Doji Star
2022-07-29: ADX>33, DI+ > 34, Crossing 4 week High
MY analysis may not be correct ... otherwise, I should be rich enough to do something else.
Please spend time on your own research before taking a call.
In the last 2 weeks - we see a slow and steady growth from 95 to 111. Expected to test 121 and beyond.
2022-07-18: Close is above SMA 20 on Daily/Weekly/Monthly time frames. M trend is +ve & W trend Change to +ve today. Price Crossed Upside 50-SMA on Monthly time frame. D13>34>55 & Close crossed D13 Up W Close Crossed W13 Upside. Also Normal NR7 - Breakout
2022-07-19: Cross WK Piv Upside & W SMA 13>34>55 & Close crossed W13 Upside
2022-07-20: SMA 30 crossed SMA 100 Upside. Possible Long. Also Crossing 4 week High
2022-07-21: Possible strong upside movement
2022-07-25: Spike in ADX. ADX >26 DI+ > 32 (Don't miss this)
2022-07-26: Increase in ADX. Also Normal NR7 - Inside Candle
2022-07-27: Normal NR7 - Breakout
2022-07-28: ADX>31, DI+> 33.0, Doji Star
2022-07-29: ADX>33, DI+ > 34, Crossing 4 week High
MY analysis may not be correct ... otherwise, I should be rich enough to do something else.
Please spend time on your own research before taking a call.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.